1. Should the Increased Awareness of the One Health Approach Brought by the COVID-19 Pandemic Be Used to Further Tackle the Challenge of Antimicrobial Resistance?
- Author
-
Michelle Tessier, Hélène Carabin, Cécile Aenishaenslin, Mohamed Rhouma, Pascal Sanders, Faculté de Médecine Vétérinaire [UdeM-Saint-Hyacinthe] (FMV - UdeM), Université de Montréal (UdeM), Groupe de Recherche en Épidémiologie des Zoonoses et Santé Publique (GREZOSP), Public Health Agency of Canada (PHAC), Laboratoire de Fougères - ANSES, and Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES)
- Subjects
antibiotic resistance ,MESH: Drug Resistance, Microbial ,résistance aux antibiotiques ,MESH: One Health ,veterinary drug ,Biochemistry ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Pandemic ,MESH: COVID-19 ,Pharmacology (medical) ,Veterinary drug ,médicament humain ,General Pharmacology, Toxicology and Pharmaceutics ,human drug ,[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,0303 health sciences ,une seule santé ,3. Good health ,Infectious Diseases ,One Health ,covid-19 ,Scale (social sciences) ,Perspective ,Biocides ,farm animals ,Microbiology (medical) ,médicament vétérinaire ,Coronavirus disease 2019 (COVID-19) ,RM1-950 ,Microbiology ,one health ,03 medical and health sciences ,résistance aux antimicrobiens ,Antibiotic resistance ,Development economics ,MESH: SARS-CoV-2 ,antimicrobial resistance ,030304 developmental biology ,Sustainable solutions ,[SDV.BA.MVSA]Life Sciences [q-bio]/Animal biology/Veterinary medicine and animal Health ,SARS-CoV-2 ,030306 microbiology ,biocide ,antimicrobial use ,Antimicrobial use ,13. Climate action ,[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Therapeutics. Pharmacology ,Business - Abstract
International audience; Several experts have expressed their concerns regarding the potential increase in antimicrobial resistance (AMR) during the COVID-19 pandemic as a consequence of the increase in antimicrobial and biocide use in humans globally. However, the impact of the pandemic on antimicrobial use (AMU) and AMR in animals has yet to be discussed and evaluated. Indeed, veterinary practices have been hugely impacted by the pandemic and its restrictive measures around the world. In this perspective, we call for more research to estimate the impact of COVID-19 on AMU and AMR in both humans and animals, as well as on the environment, in coherence with the One Health approach. In addition, we argue that the current pandemic is an opportunity to accelerate the implementation of a One Health approach to tackle the AMR crisis at the global scale. Indeed, the momentum created by the increased general awareness of both the public and decision-makers for the development and maintenance of effective drugs to treat human infections, as well as for the importance of a One Health approach to prevent the emergence of infectious diseases, should be used as a lever to implement global collaborative and sustainable solutions to the complex challenges of AMR.
- Published
- 2021